News

Reducing health spending by means of innovative workflow & technology.

Aging-Well

The population over 60 is expected to double to 22 percent, reaching 2.1 billion from 2000 to 2050.  Dr. William Haseltine discusses his new book “Aging Well” that looks at ways to support the health and well-being of older adults and offers caregivers, policymakers, and healthcare leaders insights into reducing health spending especially by means of innovative workflow and novel digital health technology.

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Cancer?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

William A. Haseltine is the Chair and President of ACCESS Health International, a nonprofit organization that works to ensure that all people, no matter their age or where they live, have access to high-quality affordable healthcare. He has an active career in science, business, and philanthropy. He is known for his pioneering work on cancer, HIV/AIDS, and genomics. Dr. Haseltine was a professor at Harvard Medical School and Harvard School of Public Health, and founder of its Division of Biochemical Pharmacology and Division of Human Retrovirology. He has founded twelve biotechnology companies, including Human Genome Sciences, Inc. Eight pharmaceutical products from companies he founded are currently approved by US and international regulatory agencies.

Last updated: January 28, 2020

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.